Team

Our specialist consulting team is dedicated to the pharma/biotech industry. We all have prior professional experience from pharma, biotech and/or consulting.

John Rountree Partner

MBA, London Business School; MA, University of Oxford
John Rountree

John has over 30 years of experience in strategy and management consulting. He founded Novasecta to apply top quality consulting craft with an exclusive focus on the pharmaceuticals and medical products sector. John has supported clients through many major initiatives with impact spanning new business strategies, organisational change, corporate transformation, improved R&D portfolios, and improved strategic partnerships.

Prior to founding Novasecta, John held senior positions in three global consulting firms, Analysis Group, Strategic Decisions Group, and Deloitte Haskins & Sells. He has also raised funds for and commercially developed start-up companies, and has been an executive board member of two start-up biotechs from the University of Cambridge.

John holds an MBA from London Business School, and an MA in Engineering, Economics and Management from Brasenose College, Oxford University.

Brian McGee Principal

PhD & MA, University of Cambridge
Brian McGee

Brian leads a broad range of engagements with Novasecta clients in the pharmaceutical and medical products industries. He has worked primarily in business unit strategy, product launch strategy, generic drug strategy, pipeline valuation, and partnership search.

Prior to Novasecta, Brian held a variety of finance and commercial positions with GlaxoSmithKline, and started his career as a strategy consultant with the Monitor Group (now Monitor Deloitte).

Brian holds a PhD in Cell and Organism Engineering, and an MA in Natural Sciences, both from the University of Cambridge.

Ed Corbett Principal

MA, University of Oxford
Ed Corbett

Ed leads a broad selection of engagements at Novasecta, but with a particular focus on commercial improvement in the pharmaceutical industry.

Prior to joining Novasecta, Ed worked for almost 15 years in the pharmaceutical industry for both Merck and GSK, holding a variety of senior marketing positions at country and global level. His experience includes multiple product launches at country and global level, portfolio management and mature product optimisation.

Ed holds an MA in Biological Sciences from Oxford University. In addition he holds a lean Six Sigma Black Belt and is PRINCE2 project management trained.

Darrell Baker Adviser

BSc Bristol University
Darrell Baker

Darrell is an Adviser at Novasecta and brings over 35 years of direct experience in the pharmaceutical industry with GlaxoSmithKline as a leader of commercial and clinical development teams on major global pharmaceutical brands.

Darrell has extensive R&D and commercialisation experience, within Europe and the US at VP level and globally at SVP level in GSK. He has led major product developments on a global scale, generating and integrating regulatory, medical, payer and prescriber insights into successful strategies and operational plans.

In addition to his commercial experience he has had a SVP R&D role for 8 years, including membership of the R&D Leadership team at a time requiring organisational planning and change management in R&D.

Darrell holds a BSc in Biochemistry from Bristol University.

Tony Sedgwick Adviser

PhD & FRCPath, St. Bartholomew’s Hospital Medical School
Tony Sedgwick

Tony is an Adviser with Novasecta and has over 30 years of experience in senior executive and non-executive roles in the pharmaceutical and biotech industry. At Novasecta, Tony has primarily been involved in R&D performance improvement, transformation, and business development.

Tony initially worked in senior management roles at Roche for 16 years including Global Head of Clinical Operations for almost 8 years. Since 2002, he has held several executive and non-executive roles in biotech companies in Europe. As CEO, he led successful trade sales of Cambridge Biotechnology and DanioLabs. Tony also successfully secured additional funding for Novacta Biosystems and Silence Therapeutics.

Tony holds a PhD FRCPath in Pathology/Experimental Pathology from St. Bartholomew’s Hospital Medical School in London.

Chris Roe Adviser

Executive Leadership, IMD Lausanne; BSc, Manchester Business School
Chris Roe

Chris is an Adviser with Novasecta and has over 23 years of management consulting experience. He previously held a senior management team position in IMS Consulting Group. During his time at IMS, Chris led the Product and Portfolio Strategy Practice in EMEA.

Chris also co-founded and was COO of a consulting firm that focused on the strategic use of sponsorship for clients spanning multiple market sectors. Earlier in his career, Chris was a Senior Associate at Strategic Decisions Group (SDG) where, as with IMS Consulting Group, much of his client experience focused on the life sciences sector. Chris has led strategic projects in life cycle management, R&D, devices and market entry across multiple developed and emerging international markets.

Chris has a BSc in Management Science at what is now part of the Manchester Business School and has been tutored in Executive Leadership at IMD in Lausanne.

 

Our Partners, Principals and Advisers are supported by a strong group of Managers and Consultants to ensure the right balance of skills and experience are applied in each of the consulting teams that works with our clients.